Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following

J K French1, I T Straznicky, B J Webber

  • 1Department of Cardiology, Green Lane Hospital, Private Bag 92189, Auckland 1030, New Zealand. johnf@ahsl.co.nz

Insights

The 90-minute corrected thrombolysis in myocardial infarction frame count (CTFC) predicts heart function after treatment. Higher CTFC values indicate better left ventricular function post-myocardial infarction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Myocardial infarction (MI) treatment aims to restore blood flow and preserve left ventricular (LV) function.
  • Early assessment of reperfusion and its impact on LV function is crucial for patient outcomes.

Purpose of the Study:

  • To determine if the 90-minute corrected thrombolysis in myocardial infarction frame count (CTFC) in the infarct-related artery predicts LV function at 48 hours.
  • To evaluate the predictive value of CTFC in patients receiving aspirin, streptokinase, and either heparin or Hirulog.

Main Methods:

  • Analysis of 251 patients from the HERO-1 trial with acute MI.
  • Coronary angiography performed at 90 minutes to calculate CTFC in the infarct-related artery.
  • Left ventriculography at 48 hours to assess LV function (ejection fraction, end-systolic volume, infarct zone score).

Main Results:

  • A CTFC ≤ 40 frames at 90 minutes was associated with significantly better LV function at 48 hours.
  • This included a lower mean chord score, smaller fraction of chords below normal, smaller end-systolic volume, and higher LV ejection fraction.
  • A CTFC ≤ 27 frames also showed trends towards improved LV function.

Conclusions:

  • The 90-minute CTFC is a reliable predictor of left ventricular function 48 hours after streptokinase treatment for myocardial infarction.
  • The optimal CTFC threshold for predicting better ventricular function may be higher than previously established values from non-infarct populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...